CN112273503A - Tea bag and preparation method and application method thereof - Google Patents
Tea bag and preparation method and application method thereof Download PDFInfo
- Publication number
- CN112273503A CN112273503A CN201910684094.1A CN201910684094A CN112273503A CN 112273503 A CN112273503 A CN 112273503A CN 201910684094 A CN201910684094 A CN 201910684094A CN 112273503 A CN112273503 A CN 112273503A
- Authority
- CN
- China
- Prior art keywords
- tea bag
- tea
- herba
- chicory
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 30
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 30
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 28
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 28
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 27
- 201000005569 Gout Diseases 0.000 claims abstract description 23
- 241000208688 Eucommia Species 0.000 claims abstract description 17
- 240000005859 Orthosiphon aristatus Species 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 241001251949 Xanthium sibiricum Species 0.000 claims abstract description 7
- 241001122767 Theaceae Species 0.000 claims description 66
- 241000723343 Cichorium Species 0.000 claims description 27
- 241000522190 Desmodium Species 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 240000002262 Litsea cubeba Species 0.000 claims description 21
- 235000012854 Litsea cubeba Nutrition 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 20
- 238000007789 sealing Methods 0.000 claims description 18
- 244000237330 gutta percha tree Species 0.000 claims description 12
- 238000005520 cutting process Methods 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 241000282326 Felis catus Species 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 7
- 241001349804 Juncus alpinoarticulatus Species 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000010025 steaming Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 abstract description 55
- 208000024891 symptom Diseases 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 21
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 201000001431 Hyperuricemia Diseases 0.000 abstract description 8
- 206010029148 Nephrolithiasis Diseases 0.000 abstract description 8
- 208000000913 Kidney Calculi Diseases 0.000 abstract description 7
- 201000001421 hyperglycemia Diseases 0.000 abstract description 6
- 210000001835 viscera Anatomy 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 235000014102 seafood Nutrition 0.000 abstract description 5
- 201000009160 urethral calculus Diseases 0.000 abstract description 5
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 235000013405 beer Nutrition 0.000 abstract description 4
- 201000003146 cystitis Diseases 0.000 abstract description 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 201000008383 nephritis Diseases 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 239000004575 stone Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 3
- 201000001352 cholecystitis Diseases 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 208000006454 hepatitis Diseases 0.000 abstract description 3
- 231100000283 hepatitis Toxicity 0.000 abstract description 3
- 201000007094 prostatitis Diseases 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 208000000143 urethritis Diseases 0.000 abstract description 3
- 208000001130 gallstones Diseases 0.000 abstract description 2
- 235000015092 herbal tea Nutrition 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 4
- 244000298479 Cichorium intybus Species 0.000 abstract 1
- 241001571764 Lysimachia christinae Species 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 16
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 13
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 13
- 229940116269 uric acid Drugs 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 8
- 210000002683 foot Anatomy 0.000 description 7
- 230000027939 micturition Effects 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 238000009210 therapy by ultrasound Methods 0.000 description 5
- 230000002485 urinary effect Effects 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000031868 Calculus ureteric Diseases 0.000 description 3
- 206010007026 Calculus urethral Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000000014 Ureteral Calculi Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 201000001883 cholelithiasis Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- -1 coniferyl alcohol ester Chemical class 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 101710083587 Antifungal protein Proteins 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 206010006987 Calculus bladder Diseases 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 239000000899 Gutta-Percha Substances 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000000342 Palaquium gutta Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 201000000210 bladder calculus Diseases 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 1
- 150000008371 chromenes Chemical class 0.000 description 1
- 231100000850 chronic interstitial nephritis Toxicity 0.000 description 1
- 229930016920 cichoric acid Natural products 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- JMFRWRFFLBVWSI-NSCUHMNNSA-N coniferyl alcohol Natural products COC1=CC(\C=C\CO)=CC=C1O JMFRWRFFLBVWSI-NSCUHMNNSA-N 0.000 description 1
- 229940119526 coniferyl alcohol Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- ROQLTZUOXIQBDO-UHFFFAOYSA-O cyanidin 3-(6''-malonylglucoside) Chemical compound OC1C(O)C(O)C(COC(=O)CC(O)=O)OC1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 ROQLTZUOXIQBDO-UHFFFAOYSA-O 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 description 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 229920000588 gutta-percha Polymers 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- VJQAFLAZRVKAKM-QQUHWDOBSA-N lactucin Chemical compound O[C@@H]1CC(C)=C2C(=O)C=C(CO)[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 VJQAFLAZRVKAKM-QQUHWDOBSA-N 0.000 description 1
- VJQAFLAZRVKAKM-UHFFFAOYSA-N lactucine Natural products OC1CC(C)=C2C(=O)C=C(CO)C2C2OC(=O)C(=C)C21 VJQAFLAZRVKAKM-UHFFFAOYSA-N 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000000387 litholytic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 210000001226 toe joint Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 210000003857 wrist joint Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of traditional Chinese medicines, in particular to a tea bag, a preparation method and an application method thereof, and the tea bag at least comprises the following components in parts by weight: is prepared from Siberian cocklebur stem 2 parts, Orthosiphon aristatus 2 parts, gynostemma pentaphyllum 2 parts, kudzu vine root 1.5 parts, lysimachia christinae 1 part, eucommia bark 1 part, and chicory 1 part. The tea bag is a herbal tea bag, has multiple effects of regulating and treating hyperuricemia and complicating diseases thereof by taking a tea, adopts pure natural raw materials, has good curative effect, quick response and no toxic or side effect, and has the functions of regulating and treating gout, diabetes and complicating diseases caused by the gout, the diabetes, hypertension, hyperlipidemia, hyperglycemia, hyperuricemia, gallstone, kidney stone, vesical stone, ureteral stone, urethral stone, cholecystitis, hepatitis, nephritis, cystitis, urethritis and prostatitis; the composition is taken orally 1 time in the morning, noon and evening, and 100 bags are taken continuously for a treatment course until symptoms completely disappear, and the patient is fasted for food such as seafood, beer, animal viscera, etc., and the severe patient can take the composition for three to four treatment courses.
Description
Technical Field
The invention relates to the field of health preservation and health care, in particular to a tea bag and a preparation method and an application method thereof.
Background
Gout is a group of diseases caused by purine long-term metabolic disorder or uric acid excretion reduction in vivo, and is clinically characterized by hyperuricemia, recurrent acute single arthritis, chronic nodular edema, chronic interstitial nephritis and renal calculus caused by kidney involvement and the like, and the life is threatened by the complication of cardiovascular and cerebrovascular diseases. The disease incidence rate of the disease in China is remarkably improved, and according to statistics, the disease incidence rate of the disease in large and medium cities in China is close to the foreign level. At present, western medicine can not radically cure the disease, has definite chemical medicine curative effect, takes effect quickly, treats both symptoms and root causes, has drug resistance and dependence and also has serious toxic and side effects, especially for the old and patients with liver and kidney insufficiency.
Disclosure of Invention
The invention aims to provide a herbal tea bag and a preparation method thereof, which are used for meeting the requirements of kidney washing, toxin expelling, uric acid reduction and uric acid discharge crystallization for treating gout; clearing heat, promoting urination, eliminating dampness, promoting blood circulation, removing blood stasis, relieving pain, and removing calculus; improving microcirculation, promoting blood circulation, dilating and softening blood vessel, diluting blood viscosity, inhibiting platelet aggregation, and preventing thrombosis; inhibiting the secretion of pancreatic hyperglycemia in vivo and reducing blood sugar in vivo; reducing cholesterol and triglyceride, and reducing blood lipid.
In order to achieve the technical purpose and achieve the technical effect, the invention discloses a tea bag which at least comprises the following components in parts by weight:
preferably, the composition comprises the following components:
the invention also discloses a preparation method of the tea bag, which comprises the following steps:
preparing materials: weighing the components in parts by weight, namely, the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory for later use;
pretreatment: cleaning the Siberian cocklebur fruit, the Chinese alpine rush, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia bark and the chicory by a medicine washing machine, and carrying out cold water soaking or steaming on the cleaned components;
cutting: respectively cutting the pretreated litsea cubeba, the cat's-hair, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory for later use;
drying: respectively enabling the water content of the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory to reach preset values by using drying equipment;
crushing: respectively placing the dried litsea cubeba, the cat grass, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory into a traditional Chinese medicine grinder for grinding;
screening: sieving pulverized caulis Litseae, herba Ordosiae Setchuensis, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii respectively;
packaging: mixing sieved caulis Kadsurae Longipedunculatae, herba Ordosicae, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii, placing into a non-woven bag, and sealing;
and (3) disinfection: and (5) ultraviolet disinfection.
Preferably, the drying equipment is a micro-thin dryer, and the drying temperature is 60-80 ℃;
preferably, the predetermined value of water content is 3% -5%;
preferably, the mesh number of the used screen for sieving is 80-100 meshes;
preferably, the weight of the seven traditional Chinese medicine compositions in each non-woven bag tea bag is 10g, and the size of the non-woven bag is 8cmx12 cm;
preferably, the non-woven bag tea bag sealing mode is sealing by a hand-press plastic sealing machine;
the invention also discloses an application method of the tea bag, which comprises the following steps:
the tea bag is used for brewing for 5-15 minutes by hot water, the temperature of the hot boiled water is kept at 100 degrees, 10 grams of the tea bag is taken each time, the tea bag is taken 1 time each in the morning, at noon and at night, 100 bags are taken continuously for one treatment course until symptoms completely disappear, food is fasted during the taking period, such as seafood, beer, animal viscera and the like, the food is fasted for a short time before and after the tea bag is taken, and the tea bag is fasted for uncooked and spicy food and can be taken by serious patients for three to four treatment courses.
The invention also provides the following main components and drug properties of the components in the traditional Chinese medicine formula:
siberian cocklebur fruit: bitter and neutral. It enters liver and kidney meridians. The main components comprise phenolic components, resin and triterpene; wherein the resin mainly comprises Sumen resin acid and coniferyl alcohol ester of cinnamic acid. Has effects of relieving damp-heat in liver and gallbladder, abdominal pain, diarrhea, pollakisuria, urgent micturition, odynuria, uric acid lowering, litholysis, dysuresia, etc.
Herba Orthosiphon aristatus: bitter and cool. It enters liver, kidney and bladder meridians. The main components comprise flavonoids, phenolic compounds, diterpenes, triterpenes, lignans, chromenes, alkyl glycosides, steroid saponins, anthraquinones, amino acids, polypeptides, proteins, vitamins, minerals, organic acids, etc. Has diuretic, antibacterial, antiinflammatory, litholytic, calculus removing and antitumor effects, and has special therapeutic effects on acute nephritis, cystitis, nephrolithiasis, vesical calculus, ureteral calculus, cholelithiasis, lithangiuria, rheumatic arthritis of lower limb and pharyngitis; it can be used for treating thrombocytopenia, lowering blood pressure, reducing production of prostaglandin and thromboxane, and protecting biological membrane from peroxidation injury. The Orthosiphon aristatus can obviously increase glomerular filtration and renal circulation blood volume, promote the elimination of toxic metabolites and obviously reduce in-vivo blood uric acid. The herba Orthosiphon aristatus has effects of preventing thrombi, promoting toxic substance removal, promoting urination, and protecting kidney.
Gynostemma pentaphylla: cool in nature and slightly sweet. It enters lung, spleen and kidney meridians. The main components comprise saponin, amino acid, flavone, sugar and various inorganic elements, wherein more than 80 kinds of saponin are similar to 6 kinds of ginsenoside. Has effects in invigorating qi, invigorating spleen, relieving fatigue, resisting anoxia, regulating immunity, lowering blood pressure, reducing blood lipid, lowering blood sugar, protecting liver, resisting ulcer, treating chronic gastroenteritis, and treating chronic tracheitis.
Kudzu root: sweet, pungent and cool. It enters stomach and lung meridians. The main components include puerarin, puerarin xyloside, daidzein, daidzin, puerarin, and saponin of radix Puerariae. Has effects in expelling pathogenic factors from muscles, relieving fever, promoting salivation, quenching thirst, promoting eruption, invigorating yang, relieving diarrhea, dredging meridian passage, dilating blood vessel, promoting blood circulation, and relieving alcoholism, and can be used for treating fever due to exogenous pathogenic factor, neck and back pain, thirst, measles without adequate eruption, dysentery, diarrhea, vertigo, headache, hyperglycemia, hypertension, apoplexy, hemiplegia, thoracic obstruction, cardiodynia, and alcoholic injury. The whole body of the kudzu root is precious, the medicinal and edible values are high, the kudzu root has the reputation of Asian ginseng and is regarded as a medicine-food dual-purpose plant by the national health department.
Herba Lysimachiae Christinae: bitter, sour and slightly cold. It enters liver, gallbladder, kidney and bladder meridians. The main components comprise brass substances, triterpenes substances and trace elements. Is mainly applied to the aspects of resisting hepatitis B virus surface antigen, resisting lipid peroxidation, benefiting gallbladder and removing urinary calculus, reducing bilirubin, carbuncle and furuncle, inhibiting thrombus, acting on immune system and the like.
Eucommia ulmoides: sweet and warm. It enters liver and kidney meridians. The main components comprise lignin, iridoid, phenylpropanoid, polysaccharide, gutta Percha, flavone, amino acid, other terpenes, eucommia antifungal protein, and other components; regulating cardiovascular function, resisting virus, resisting aging, promoting bone cell proliferation, resisting tumor, relieving inflammation, promoting urination, promoting gallbladder function, reducing blood lipid, preventing miscarriage, enhancing muscle function, and inhibiting central nervous system.
Chicory: slightly bitter, salty and cool. It enters liver, gallbladder and stomach meridians. The main components comprise lactucin, chicoric acid, castanein, cyanidin-3-malonyl glucoside, caffeic acid and the like, and the Chinese medicinal composition has the effects of clearing liver and promoting bile flow, invigorating stomach and promoting digestion, and inducing diuresis and reducing edema.
Compared with the prior art, the invention has the following advantages and beneficial effects:
the traditional Chinese medicine has the advantages of small toxic reaction, treatment of both principal and secondary aspects of diseases, does not cause patients to have dependence on the medicine and drug resistance, can radically improve gout symptoms, can improve symptoms in an acute stage, can regulate viscera functions in a chronic stage and a remission stage, and balances qi and blood of organisms, thereby reducing relapse.
According to the tea bag and the preparation method and the application method thereof, the pure natural raw materials are adopted, so that the tea bag is good in curative effect, quick in effect taking and free of toxic and side effects, and can better protect the body health of a patient; has therapeutic effects on gout, diabetes, and complications caused by diabetes, hypertension, hyperlipidemia, hyperglycemia, hyperuricemia, cholelithiasis, renal calculus, vesical calculus, ureteral calculus, urethral calculus, cholecystitis, hepatitis, nephritis, cystitis, urethritis, and prostatitis. Washing kidney to expel toxin, reducing uric acid and discharging uric acid crystal to treat gout; clearing heat, promoting urination, eliminating dampness, promoting blood circulation, removing blood stasis, relieving pain, and removing calculus; improving microcirculation, promoting blood circulation, dilating and softening blood vessel, diluting blood viscosity, inhibiting platelet aggregation, and preventing thrombosis; inhibiting the secretion of pancreatic hyperglycemia in vivo and reducing blood sugar in vivo; reducing cholesterol and triglyceride, and reducing blood lipid.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments.
Example 1
The tea bag in the embodiment takes parts by weight as a unit, and comprises the following components:
the preparation steps of the tea bag in the embodiment are as follows:
preparing materials: weighing the components in parts by weight, namely, the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory for later use;
pretreatment: cleaning the Siberian cocklebur fruit, the Chinese alpine rush, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia bark and the chicory by a medicine washing machine, and carrying out cold water soaking or steaming on the cleaned components;
cutting: respectively cutting the pretreated litsea cubeba, the cat's-hair, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory for later use;
drying: respectively enabling the water content of the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory to reach preset values by using drying equipment;
crushing: respectively placing the dried litsea cubeba, the cat grass, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory into a traditional Chinese medicine grinder for grinding;
screening: sieving pulverized caulis Litseae, herba Ordosiae Setchuensis, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii respectively;
packaging: mixing sieved caulis Kadsurae Longipedunculatae, herba Ordosicae, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii, placing into a non-woven bag, and sealing;
and (3) disinfection: and (5) ultraviolet disinfection.
Preferably, the drying equipment is a micro-thin dryer, and the drying temperature is 70 ℃;
preferably, the predetermined value of water content is 5%;
preferably, the mesh number of the used screen for sieving is 80-100 meshes;
preferably, the weight of the seven traditional Chinese medicine compositions in each non-woven bag tea bag is 10g, and the size of the non-woven bag is 8cmx12 cm;
preferably, the non-woven bag tea bag sealing mode is sealing by a hand-press plastic sealing machine;
the tea bag is applied to treatment of gout and complications thereof in the above embodiments, the tea bag is brewed with hot water for 5-15 minutes when in use, the temperature of the hot boiled water is kept at 100 degrees, 10 grams of tea is taken each time, the tea bag is taken 1 time each in the morning, the evening and the morning, 100 bags are taken continuously as a treatment course until symptoms completely disappear, food is fasted during taking, such as seafood, beer, animal viscera and the like, the food is fasted for a short time before and after taking the tea, and the tea bag is taken for a long time and is uncooked and spicy, and a serious person can take the tea bag for three to four treatment.
Example 2
The tea bag in the embodiment takes parts by weight as a unit, and comprises the following components:
the preparation steps of the tea bag in the embodiment are as follows:
preparing materials: weighing the components in parts by weight, namely, the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory for later use;
pretreatment: cleaning the Siberian cocklebur fruit, the Chinese alpine rush, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia bark and the chicory by a medicine washing machine, and carrying out cold water soaking or steaming on the cleaned components;
cutting: respectively cutting the pretreated litsea cubeba, the cat's-hair, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory for later use;
drying: respectively enabling the water content of the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory to reach preset values by using drying equipment;
crushing: respectively placing the dried litsea cubeba, the cat grass, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory into a traditional Chinese medicine grinder for grinding;
screening: sieving pulverized caulis Litseae, herba Ordosiae Setchuensis, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii respectively;
packaging: mixing sieved caulis Kadsurae Longipedunculatae, herba Ordosicae, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii, placing into a non-woven bag, and sealing;
and (3) disinfection: and (5) ultraviolet disinfection.
Preferably, the drying equipment is a micro-thin dryer, and the drying temperature is 60 ℃;
preferably, the predetermined value of water content is 4%;
preferably, the mesh number of the used screen for sieving is 80-100 meshes;
preferably, the weight of the seven traditional Chinese medicine compositions in each non-woven bag tea bag is 10g, and the size of the non-woven bag is 8cmx12 cm;
preferably, the non-woven bag tea bag sealing mode is sealing by a hand-press plastic sealing machine;
the tea bag in the embodiment is applied to treatment of gout and complications thereof, when the tea bag is used, hot water is used for brewing for 5-15 minutes, the temperature of the hot water is kept at 100 degrees, 10 grams of tea is taken each time, the tea bag is taken 1 time each time in the morning, at noon and at night, 100 bags are taken continuously as a treatment course until symptoms completely disappear, and fasting materials such as seafood, animal viscera and the like are taken during the taking period, and the tea bag is fasted, uncooked, cold, spicy and hot within a short time.
Example 3
The tea bag in the embodiment takes parts by weight as a unit, and comprises the following components:
the preparation steps of the tea bag in the embodiment are as follows:
preparing materials: weighing the components in parts by weight, namely, the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory for later use;
pretreatment: cleaning the Siberian cocklebur fruit, the Chinese alpine rush, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia bark and the chicory by a medicine washing machine, and carrying out cold water soaking or steaming on the cleaned components;
cutting: respectively cutting the pretreated litsea cubeba, the cat's-hair, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory for later use;
drying: respectively enabling the water content of the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory to reach preset values by using drying equipment;
crushing: respectively placing the dried litsea cubeba, the cat grass, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory into a traditional Chinese medicine grinder for grinding;
screening: sieving pulverized caulis Litseae, herba Ordosiae Setchuensis, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii respectively;
packaging: mixing sieved caulis Kadsurae Longipedunculatae, herba Ordosicae, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii, placing into a non-woven bag, and sealing;
and (3) disinfection: and (5) ultraviolet disinfection.
Preferably, the drying equipment is a micro-thin dryer, and the drying temperature is 80 ℃;
preferably, the predetermined value of water content is 3%;
preferably, the mesh number of the used screen for sieving is 80-100 meshes;
preferably, the weight of the seven traditional Chinese medicine compositions in each non-woven bag tea bag is 10g, and the size of the non-woven bag is 8cmx12 cm;
preferably, the non-woven bag tea bag sealing mode is sealing by a hand-press plastic sealing machine;
the tea bag in the embodiment is applied to treatment of gout and complications thereof, when the tea bag is used, hot water is used for brewing for 5-15 minutes, the temperature of the hot water is kept at 100 degrees, 10 grams of tea is taken each time, the tea bag is taken 1 time each time in the morning, at noon and at night, 100 bags are taken continuously as a treatment course until symptoms are completely disappeared, fasting matters such as seafood, beer, animal viscera and the like are taken during the taking period, and the tea bag is fasted, uncooked, cold, spicy and hot within a short time before and after the tea bag is taken.
Selecting 5 patients with gout, taking 10g of corresponding tea bags for each patient three times a day, taking 100 parts of tea bags for 1 treatment course, keeping 1-3 treatment courses according to conditions, recording whether gout symptoms of the patients are improved, whether the tea bags are effective, and recording whether symptoms relapse every 3 months:
case 1
Patient old Mr. 35 years old man
The main complaints are: repeating swelling and pain of foot joint for more than ten years
The red, swollen and hot swelling of the 1 st metatarsophalangeal joint of the feet on both sides, the ankle joints on both sides, the pain during the attack can not be bent and stretched, and the swelling is obvious
And (4) assay: serum uric acid: 587umol/l
Ultrasonic treatment of urinary system: signs of renal calculus and vesical calculus
The course of treatment is as follows: example 1, 2 courses of administration
The effect is as follows: the swelling of the toe joint is obviously relieved, and the symptoms such as gout, pain in urination, hyperuricemia syndrome and the like are obviously felt to be relieved.
Recurrence of the disease: whether or not
Case 2
Patient Mr. Pueraria 55 years old
The main complaints are: obvious pain of elbow joint, wrist joint and knee joint
Red, swollen and heat-swollen involving the 1 st metatarsophalangeal joint of the left foot
And (4) assay: serum uric acid: 502umol/l
Ultrasonic treatment of urinary system: no signs of calculus
The course of treatment is as follows: example 1, 2 courses of administration
The effect is as follows: obviously feels that the symptoms of the left 1 st metatarsophalangeal joint detumescence, gout, odynuria, hyperuricemia syndrome and the like are relieved.
Recurrence of the disease: whether or not
Case 3
Patient Cao's Mr. 80 year old man
The main complaints are: pain of knee joints repeatedly for 5 years
Involving the 1 st metatarsophalangeal joint and the bilateral ankle joints of the feet, frequent urination and painful urination
And (4) assay: serum uric acid: 747umol/l
Ultrasonic treatment of urinary system: symptoms of renal calculus, urethral calculus, and bladder calculus
The course of treatment is as follows: example 1, 3 courses of administration
The effect is as follows: obviously relieve the symptoms of the 1 st metatarsophalangeal joint detumescence, gout, odynuria, hyperuricemia syndrome and the like of the feet at both sides.
Recurrence of the disease: whether or not
Case 4
Patient Mr. Huang man 33 years old
The main complaints are: repeating the 1 st metatarsophalangeal joint swelling and pain of the left foot for 2 years (after being taken once two years ago and treated by the non-steroidal anti-inflammatory drug for 7 days, the symptoms are relieved, and the 1 st metatarsophalangeal joint swelling and pain of the right foot appears again after drinking a large amount of wine once three months ago.)
And (4) assay: serum uric acid: 507umol/l
Ultrasonic treatment of urinary system: no signs of calculus
The course of treatment is as follows: example 2, 1 course of treatment
The effect is as follows: obviously feels the detumescence of the 1 st metatarsophalangeal joint of the right foot and relieves the gout symptoms.
Recurrence of the disease: whether or not
Case 5
Patient Mr. Li 60 year old male
The main complaints are: fever symptoms sometimes occur simultaneously when severe pain and joint inflammation begin to occur at night, and the onset of such a condition is often caused by overeating, especially after dinner, alcohol, drugs, trauma or surgery, and sometimes after ankle sprain
And (4) assay: serum uric acid: 557umol/l
Ultrasonic treatment of urinary system: symptoms of cholelithiasis, renal calculus, ureteral calculus, and urethral calculus
The course of treatment is as follows: example 3, 2 courses of treatment
The effect is as follows: obviously feels that the symptoms of gout and calculus are relieved
Recurrence of the disease: whether or not
Patients with gout and complications thereof are taken one bag of boiled water in the morning, at noon and at night every day, and 100 small bags are taken as a treatment course; in the course of treatment, uric acid/calculus/thrombus/blood sugar and other focal areas have swelling and pain feeling, urine is increased, urine is yellow and viscous, and fishy smell, and the phenomena of normal acid discharge, thrombolysis, fossil reduction, blood sugar reduction and blood fat reduction are generated. The urine is normal the next day, the nocturia is reduced or not, the distending pain gradually disappears, the sleep is improved, and the red and swollen focus is subsided. Patients with mild symptoms can take the medicine for one course of treatment (the later period can be used for strengthening the treatment), patients with moderate symptoms take the medicine for two courses of treatment, and patients with severe symptoms take the medicine for three to four courses of treatment.
According to the above results, after drinking the tea bag provided by the invention and the preparation method thereof, the gout and the symptoms of complications of the gout are relieved, the effective components of the seven traditional Chinese medicine tea raw materials including the litsea cubeba, the Chinese alpine rush, the fiveleaf gynostemma herb, the kudzuvine root, the desmodium, the eucommia ulmoides and the chicory are fully released by the preparation method, and then the effective substances are fully exerted in the body of a patient when people drink the tea bag, so that the tea bag provided by the invention has the effects of treating the gout and the complications caused by the gout, such as hypertension, hyperlipidemia, hyperglycemia, hyperuricemia, gallstone, kidney stone, vesical stone, ureteral stone, urethral stone, cholecystitis, hepatitis, nephritis, cystitis, urethritis and prostatitis.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope of the present invention are included in the scope of the present invention.
Claims (10)
1. The tea bag is characterized by comprising the following components in parts by weight:
2. the tea bag according to claim 1, wherein the tea bag comprises at least the following components in parts by weight:
3. a method of making a tea bag according to claims 1-2 comprising the steps of:
preparing materials: weighing the components in parts by weight, namely, the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory for later use;
pretreatment: cleaning the Siberian cocklebur fruit, the Chinese alpine rush, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia bark and the chicory by a medicine washing machine, and carrying out cold water soaking or steaming on the cleaned components;
cutting: respectively cutting the pretreated litsea cubeba, the cat's-hair, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia and the chicory for later use;
drying: respectively enabling the water content of the litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia ulmoides and the chicory to reach preset values by using drying equipment;
crushing: respectively placing the dried litsea cubeba, the Orthosiphon aristatus, the gynostemma pentaphylla, the kudzu root, the desmodium, the eucommia bark and the chicory into a traditional Chinese medicine grinder for grinding,
screening: sieving pulverized caulis Litseae, herba Ordosiae Setchuensis, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii respectively;
packaging: mixing sieved caulis Kadsurae Longipedunculatae, herba Ordosicae, herba Gynostemmatis, radix Puerariae, herba Lysimachiae Christinae, Eucommiae cortex and herba Cichorii, placing into a non-woven bag, and sealing;
and (3) disinfection: and (5) ultraviolet disinfection.
4. The method for preparing tea bags according to claim 3, wherein the drying equipment is a slim dryer and the drying temperature is 60 ℃ to 80 ℃.
5. A process for the preparation of tea bags according to claim 3, wherein the predetermined value of moisture content is between 3% and 5%.
6. The method for preparing tea bags according to claim 3, wherein the mesh number of the screen used for sieving is 80-100 mesh.
7. The method for preparing tea bags according to claim 3, wherein the weight of the seven Chinese medicinal compositions in each non-woven bag tea bag is 10g, and the size of the non-woven bag is 8cmx12 cm.
8. The method for preparing the tea bag according to claim 3, wherein the non-woven bag tea bag is sealed by a hand-press type plastic sealing machine.
9. A method of using the tea bag according to claims 1-2, wherein the tea bag is used for the treatment of gout and its complications.
10. The method of applying the tea bag according to claim 9, wherein the method of applying comprises: when the tea bag is used, the tea bag is brewed with hot boiled water for 5-15 minutes, and the temperature of the hot water is kept at 100 degrees.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910684094.1A CN112273503A (en) | 2019-07-26 | 2019-07-26 | Tea bag and preparation method and application method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910684094.1A CN112273503A (en) | 2019-07-26 | 2019-07-26 | Tea bag and preparation method and application method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112273503A true CN112273503A (en) | 2021-01-29 |
Family
ID=74419337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910684094.1A Pending CN112273503A (en) | 2019-07-26 | 2019-07-26 | Tea bag and preparation method and application method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112273503A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114195908A (en) * | 2021-12-20 | 2022-03-18 | 右江民族医学院 | Enzyme extraction and purification process of polysaccharide from leaves of litsea cubeba |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1970008A (en) * | 2006-11-29 | 2007-05-30 | 李敬谋 | Health tea capable of lowering blood pressure and decreasing blood fat and preparation process thereof |
| CN104996622A (en) * | 2015-06-16 | 2015-10-28 | 武汉轻工大学 | Uric acid reducing tea and preparation method thereof |
| CN107951922A (en) * | 2017-12-08 | 2018-04-24 | 杨英珠 | Erythropalum Scandens Blume deacidification tea and preparation method thereof |
| CN108887444A (en) * | 2018-09-25 | 2018-11-27 | 广西中医药大学 | A kind of health protection tea of anti-trioxypurine and preparation method thereof |
| US20190070240A1 (en) * | 2016-05-09 | 2019-03-07 | Shaoke WANG | Gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout |
-
2019
- 2019-07-26 CN CN201910684094.1A patent/CN112273503A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1970008A (en) * | 2006-11-29 | 2007-05-30 | 李敬谋 | Health tea capable of lowering blood pressure and decreasing blood fat and preparation process thereof |
| CN104996622A (en) * | 2015-06-16 | 2015-10-28 | 武汉轻工大学 | Uric acid reducing tea and preparation method thereof |
| US20190070240A1 (en) * | 2016-05-09 | 2019-03-07 | Shaoke WANG | Gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout |
| CN107951922A (en) * | 2017-12-08 | 2018-04-24 | 杨英珠 | Erythropalum Scandens Blume deacidification tea and preparation method thereof |
| CN108887444A (en) * | 2018-09-25 | 2018-11-27 | 广西中医药大学 | A kind of health protection tea of anti-trioxypurine and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈寿元等: "猫须草临床应用举隅", 《四川中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114195908A (en) * | 2021-12-20 | 2022-03-18 | 右江民族医学院 | Enzyme extraction and purification process of polysaccharide from leaves of litsea cubeba |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100995379B1 (en) | Body care composition and method for preparing the same | |
| CN104173696A (en) | Dressing used for postoperative nursing of appendicitis and preparation method of dressing | |
| CN103341119B (en) | Traditional Chinese medicine preparation for treating acute or chronic gastroenteritis and preparation method thereof | |
| CN112273503A (en) | Tea bag and preparation method and application method thereof | |
| CN1733176A (en) | Medicine, food used article for preventing and curing colitis and method for producing the same | |
| CN106492177A (en) | Chinese medicine composition for the treatment of intestinal cancer and diabetes and preparation method thereof | |
| CN106266763A (en) | One treats gout Chinese medicine preparation and preparation method thereof | |
| CN113975353A (en) | Medicine-food homologous nutrient solution formula for reducing uric acid and treating gout and preparation process thereof | |
| CN112294925A (en) | A medicine for treating gout, gastropathy and constipation, and its preparation method | |
| CN104940720A (en) | Traditional Chinese medicine pills for preventing and treating contrast-induced nephropathy and preparation method thereof | |
| CN111939213A (en) | Preparation method of Tibetan medicine hemorrhoid ointment for relieving swelling and pain | |
| CN106668409A (en) | Hui traditional Chinese medicine hedyotis diffusa willd anti-esophageal cancer oral liquid and preparation method thereof | |
| CN111481600A (en) | Kidney tonifying ointment | |
| CN100333755C (en) | Nephrosis treating Chinese medicine boneyed bolus and its prepn process | |
| CN108066735A (en) | A kind of Chinese medicine composition for treating chronic nephritis | |
| CN114470144B (en) | Prostate eliminating soup for inhibiting prostate fibrosis and preparation method thereof | |
| CN107224557A (en) | It is a kind of to be used to treat decoction medicine of chronic prostatitis and preparation method thereof | |
| CN108853380B (en) | Pharmaceutical composition for treating diabetes and preparation method and application thereof | |
| CN101623493A (en) | Herba artemisiae scopariae turtle shell soup for treating liver cirrhosis | |
| CN114010755A (en) | Preparation for controlling uric acid and preparation method thereof | |
| CN104667107A (en) | Medicine for treating summerheat injuring lung and stomach summer fever in children and preparation method of medicine | |
| CN105194627A (en) | Preparation for treating gill-rot disease of lateolabrax japonicus and preparation method of preparation | |
| CN105250903A (en) | Traditional Chinese medicine physiotherapeutic liquid for treating numbness of limbs and preparation method of traditional Chinese medicine physiotherapeutic liquid | |
| CN105326976A (en) | Traditional Chinese medicine liquor for treating vitiligo | |
| CN111759948A (en) | Traditional Chinese medicine composition for repairing gastrointestinal mucosa and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210129 |
|
| RJ01 | Rejection of invention patent application after publication |